USADA announced on August 12, 2011 that David Clinger, 34, of Murray, Utah, an athlete in the sport of cycling, has accepted a sanction for his second doping offense. This offense is the result of an adverse analytical finding for the anabolic agent, clenbuterol, in an out-of-competition sample collected on June 29, 2011 while Clinger was approaching the end of a two-year period of ineligibility for his first offense, the result of an adverse analytical finding for the presence of testosterone and modafinil in a sample collected in June of 2009. Clinger accepted responsibility for using clenbuterol to enhance his performance. Clenbuterol is a prohibited Anabolic Agent under the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the International Cycling Union (UCI), both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. For this second offense, Clinger received a lifetime period of ineligibility, which began on August 9, 2011.